Ehab Abdelmalak Azmy

July 2018 till Present: Line Sales Manager at Eva Pharma, Consumer Health Business Unit. According to IMS Data MAT/10/2019 sales units, Chromax market share is 57% (ranked No. 1) and PPG% 37.2, while the market PPG% 4.7. Comparing to last year Chromax performance MAT/10/2018 MS% 43.5 -PPG% 6.9 and market PPG%13.5. Team retention, no vacancies and zero % of rep’s achievement that are above or below the line achievement by 20% (right target allocation) October 2017 till June 2018 ( pedia line ) IMS MAT 6-19, Achieve 125% growth in first year of responsibility about Zofatrone (anti emetic product- injection) Shifted the line (pediatric) total portfolio achievement from the lowest between company’s lines in Q1 & Q2 2017 to be ranked the 2nd in Q1 2018 and 1st in Q2 2018